GoldenBiotech reports positive data from leukaemia drug trial
Taiwanese biopharma company Golden Biotechnology (GoldenBiotech) has reported that data from its Phase IIa clinical study conducted in Russia showed…
Latest News
-
2 days
-
2 days
-
2 days
-
3 days
-
2 days
-
2 days
-
2 days
-
3 days
Haoma Medica concludes trial of oral osteoporosis treatment
Clinical-stage biotech firm Haoma Medica has completed a first-in-human trial for novel orally administered therapeutic, NaQuinate, being developed for osteoporosis.…
Latest News
View More
Researchers conduct study to increase trial participation in New Zealand
A national team of expert clinicians and health researchers in New Zealand are leading a new study to make more people in the country participate…
Celltrion concludes enrolment in global Covid-19 antibody trial
Celltrion Group has completed enrolment of 327 patients with mild-to-moderate SARS-CoV-2 infection symptoms to evaluate anti-Covid-19 monoclonal antibody treatment candidate CT-P59 in the global Phase…
Clinigen expands partnership with Accord Healthcare into France
Pharmaceutical and services company Clinigen Group’s Clinical Services has expanded its ‘on-demand’ supply service with Accord Healthcare into France. This…
NeuroRx and Relief Therapeutics report initial results for RLF-100
NeuroRx, Relief Therapeutics have announced initial successful results from expanded access use of RLF-100 (aviptadil) in patients suffering with critical…
ReiThera’s Covid-19 vaccine shown to induce immune response in trial
Biotech firm ReiThera has reported that the preliminary results from the ongoing Phase I study showed that its Covid-19 vaccine…
Bausch Health begins second trial of NOV03 to treat dry eye disease
Bausch Health’s global eye health business Bausch + Lomb has begun the second of two Phase III studies analysing the…
Latest Content
View More
GSK begins Phase III RSV maternal candidate vaccine study
GlaxoSmithKline (GSK) has initiated dosing of patients in the Phase III clinical programme evaluating the safety and efficacy of its…
Pfizer initiates dosing in Phase III haemophilia therapy trial
Pfizer has dosed the first participant in the Phase III BASIS study of the investigational therapy, marstacimab (PF-06741086), for treating…
Nuedexta for the Treatment of Pseudobulbar Affect (PBA)
Nuedexta (dextromethorphan hydrobromide / quinidine sulfate) is a combination drug indicated for the treatment of pseudobulbar affect (PBA). The drug…
VIMPAT (lacosamide) for the Treatment of Primary Generalised Tonic-Clonic Seizures (PGTCS)
VIMPAT® (lacosamide) is a federally-controlled drug (CV) indicated as a supplementary therapy for the treatment of primary generalised tonic-clonic seizures…